Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
BPC-157 for tendon injury is administered subcutaneously near the affected tendon
Additional information Research Reviews There are no reviews yet
To date, therapies to treat intervertebral disc degeneration are limited, involving broad-spec anti-inflammatory drugs, which have undesirable side effects, or surgeries that are invasive, risky, and require long recovery times
reports quickened fibroblast migration and spreading in laboratory studies, both of which are essential for repopulating an injury site
Standard concentration: 0.5 mg/mL This is a common concentration used by many compounding pharmacies
US$ 26.43
US$ 28.81
US$ 23.02
US$ 29.90
US$ 29.80
US$ 28.82
US$ 23.69
